Eli Lilly sales and marketing update

Lilly launched Trulicity dulaglutide in the U.S. to help improve glycemic control in adults with Type 2 diabetes. The 0.75 and 1.5 mg subcutaneous single-dose pens are taken once-weekly. The wholesal...